Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bacterial Resistance”

792 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 792 results

Not applicableStudy completedNCT02727582
What this trial is testing

Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment

Who this might be right for
Multidrug-resistant Tuberculosis
University of Cape Town 142
Post-approval studies (Phase 4)Study completedNCT01732250
What this trial is testing

Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem

Who this might be right for
Gram-Negative Bacterial Infections
Mical Paul 406
Not applicableActive Not RecruitingNCT05871489
What this trial is testing

Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens

Who this might be right for
Tuberculosis, Multidrug-ResistantHIV
Harvard Medical School (HMS and HSDM) 800
Testing effectiveness (Phase 2)Study completedNCT01746654
What this trial is testing

Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients

Who this might be right for
Infectious DiseaseBacterial Infections
GangaGen, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT01604096
What this trial is testing

Controlled Trial to Evaluate a Local Information Campaign on Antibiotic Prescribing in Italy

Who this might be right for
Upper Respiratory Tract Infections
Regional Health and Social Care Agency, Italy
Testing effectiveness (Phase 2)Looking for participantsNCT05791396
What this trial is testing

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Early research (Phase 1)Study completedNCT04309656
What this trial is testing

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Who this might be right for
Multi-drug Resistant Tuberculosis
Global Alliance for TB Drug Development 48
Not applicableUnknownNCT03220386
What this trial is testing

Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making

Who this might be right for
Staphylococcus Aureus
Charite University, Berlin, Germany 1,000
Not applicableStudy completedNCT07420894
What this trial is testing

Comparison of Combination of Itraconazole and Isotretinoin Versus Itraconazole Alone in the Treatment of Resistant Trichophyton Infection

Who this might be right for
DermatophytosisTrichophyton InfectionResistant Dermatophyte Infection
Multan Medical And Dental College 148
Large-scale testing (Phase 3)Study completedNCT00035854
What this trial is testing

New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)

Who this might be right for
Bacterial Infections
Pfizer 13
Not applicableStudy completedNCT04568954
What this trial is testing

TB-CAPT CORE Truenat Trial

Who this might be right for
TuberculosisDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 3,987
Not applicableLooking for participantsNCT05286931
What this trial is testing

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection

Who this might be right for
Neisseria Gonorrhoeae Infection
University of Washington 1,800
Not applicableStudy completedNCT01184339
What this trial is testing

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

Who this might be right for
Bacteremia
MicroPhage, Inc. 1,165
Not applicableStudy completedNCT04492839
What this trial is testing

Intestinal Adsorbent and Breath Gas Levels

Who this might be right for
Gastroesophageal RefluxSmall Intestinal Bacterial Overgrowth
Dr Anthony Hobson 20
Post-approval studies (Phase 4)Ended earlyNCT00638157
What this trial is testing

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Who this might be right for
Infective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Testing effectiveness (Phase 2)Ended earlyNCT03331445
What this trial is testing

Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections

Who this might be right for
Respiratory Tract InfectionsCorona Virus Infection
Chris Miller 13
Post-approval studies (Phase 4)Study completedNCT00352612
What this trial is testing

Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections

Who this might be right for
Staphylococcal InfectionAbscessStaphylococcal Skin Infection+1 more
Aaron Chen 200
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Not applicableNot Yet RecruitingNCT06700577
What this trial is testing

Multidrug Resistance in Newly Diagnosed TB Patient

Who this might be right for
Tuberculosis
Assiut University 100
Large-scale testing (Phase 3)Ended earlyNCT00055198
What this trial is testing

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Who this might be right for
Gram-Positive Bacterial Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 75
Load More Results